Supernus Pharmaceuticals reported $16.02M in Trade Creditors for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Creditors Change
Ani Pharmaceuticals ANIP:US USD 18.99M 8.65M
Aurora Cannabis Inc ACB:CN CAD 18.21M 4.35M
Bristol Myers Squibb BMY:US USD 2.6B 287M
Canopy Growth Corp WEED:CN CAD 68.2M 3.56M
Cara Therapeutics CARA:US USD 15.22M 5.48M
Corcept Therapeutics CORT:US USD 8.18M 68K
Eisai 4523:JP JPY 76.83B 19.28B
Eli Lilly And LLY:US USD 1.68B 23.9M
Endo International Ordinary Shares ENDP:US USD 85M 5.64M
Horizon Pharma HZNP:US USD 32.11M 13.58M
Lannett LCI:US USD 24.06M 5.67M
Marinus Pharmaceuticals MRNS:US USD 1.62M 1.68M
Pacira Pharmaceuticals PCRX:US USD 12.93M 1.05M
Perrigo Ordinary Shares PRGO:US USD 461.4M 29M
Revance Therapeutics RVNC:US USD 744K 12.53M
Supernus Pharmaceuticals SUPN:US USD 16.02M 19.5M
Teva Pharmaceutical Industries TEVA:US USD 1.64B 266M
Xeris Pharmaceuticals Inc XERS:US USD 3.92M 2.72M